Structure (Cyt03 0000 01)
Cytarabine Injection, Solution
Product Images NDC 71288-169
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 71288-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Vial Label (Cyt03 0000 02)
Principal Display Panel – Cytarabine Injection 500 mg Per 25 mL Carton (Cyt03 0000 03)
This appears to be a label for a pharmaceutical product called Cytarabine that is in injection form. The label provides information on the contents of the product, storage instructions, usage instructions, and warnings. The product should not be used intrathecally or at high doses. The label also warns that the product is a cytotoxic agent. It is not clear what the text at the beginning of the label pertains to.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
